E-LIB Suche - Ergebnisse für: Ray, K.B.

1

Physica status solidi

Volume 88, Number 1: May 16 Physica status solidi ; Volume 88, Number 1, A

Aleksandrov, L. N ; Andreichin, R. E ; Apostolov, A... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

2

Physica status solidi

Volume 69, Number 1: January 16 Physica status solidi ; Volume 69, Number 1, A

Aarna, H. A ; Abdelmohsen, N ; Abdullaeva, S. G... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

3

Physica status solidi

Volume 75, Number 2: February 16 Physica status solidi ; Volume 75, Number 2, A

Abdel-Salam, F ; Abreu, R. A ; Akhmetov, V. D... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

4

Are risk-based LDL-c goals achieved in primary and secondar..:

Vrablik, M. ; Seifert, B. ; Parkhomenko, A....
Atherosclerosis. 331 (2021) - p. e23 , 2021

Link: https://doi.org/10.1016/..

5

What potential risk reduction could be achieved with evoloc..:

Ray, K.K ; Bridges, I ; Bruckert, E...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

6

Does Evolocumab use in Europe match 2019 ESC/EAS lipid guid..:

Ray, K.K ; Bruckert, E ; Van Hout, B...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

7

Lipid lowering therapy in primary and secondary prevention ..:

Ray, K.K. ; Schoonen, W.M. ; Catapano, A.L....
Atherosclerosis. 315 (2020) - p. e13 , 2020

Link: https://doi.org/10.1016/..

8

Efficacy and safety of bempedoic acid in patients with hete..:

Duell, P.B. ; Banach, M. ; Catapano, A.L....
Atherosclerosis. 315 (2020) - p. e12-e13 , 2020

Link: https://doi.org/10.1016/..

9

Effect of bempedoic acid on uric acid and gout in 3621 pati..:

Ray, K.K ; Bakris, G.L ; Banach, M...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

10

Ldl-C Lowering Among Patients With Ldl-C Above 4.9 Mmol/L A..:

Vallejo-Vaz, A.J. ; Packard, C.J. ; Ference, B.A....
Atherosclerosis. 287 (2019) - p. e6 , 2019

Link: https://doi.org/10.1016/..

11

P654Effectiveness of evolocumab for patients with familial ..:

Ray, K K ; Schoonen, M ; Annemans, L...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

12

P5364Safety profile of bempedoic acid: pooled analysis of 4..:

Ballantyne, C M ; Banach, M ; Catapano, A L...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

13

Efficacy and safety of alirocumab in insulin-treated patien..:

Cariou, B. ; Leiter, L.A. ; Müller-Wieland, D....
Diabetes & Metabolism. 43 (2017) 5 - p. 453-459 , 2017

Link: https://doi.org/10.1016/..

14

Cardiovascular risk prevention and all-cause mortality in p..:

Bahia, S S ; Vidal-Diez, A ; Seshasai, S R K...
British Journal of Surgery. 103 (2016) 12 - p. 1626-1633 , 2016

Link: https://doi.org/10.1002/..

15

Cardiovascular safety of the glucagon-like peptide-1 recept..:

Seshasai, S. R. K. ; Bennett, R. L. ; Petrie, J. R....
Diabetes, Obesity and Metabolism. 17 (2015) 5 - p. 505-510 , 2015

Link: https://doi.org/10.1111/..